Castle Biosciences (CSTL) Goodwill & Intangibles (2018 - 2026)

Castle Biosciences has reported Goodwill & Intangibles for 7 years, with the latest figure at $95.1 million in Q2 2026.

• Quarterly Goodwill & Intangibles fell 8.67% year-over-year to $95.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $95.1 million (down 8.67% YoY) and the FY2025 annual result came in at $99.6 million, down 6.26% from the prior year.
• Goodwill & Intangibles declined to $95.1 million in Q2 2026 per CSTL's latest filing, from $97.3 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $132.7 million in Q2 2022 and troughed at $77.9 million in Q1 2025.
• A 5-year average of $110.0 million and a median of $111.7 million in 2024 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2022 and 2025: Goodwill & Intangibles jumped 306.05% in 2022, then sank 32.31% in 2025.
• Over 5 years, Goodwill & Intangibles stood at $126.3 million in 2022, then retreated by 7.13% to $117.3 million in 2023, then slipped by 9.47% to $106.2 million in 2024, then dropped by 6.26% to $99.6 million in 2025, then slipped by 4.5% to $95.1 million in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $95.1 million, $97.3 million, and $99.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.